These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20021304)

  • 21. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge and attitudes about human papillomavirus (HPV) and HPV vaccines among women living in metropolitan and rural regions of China.
    Li J; Li LK; Ma JF; Wei LH; Niyazi M; Li CQ; Xu AD; Wang JB; Liang H; Belinson J; Qiao YL
    Vaccine; 2009 Feb; 27(8):1210-5. PubMed ID: 19135493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
    Paavonen J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus infection: an old disease, a new vaccine.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing.
    Schiffman M
    Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening.
    Arbyn M; Dillner J
    J Clin Virol; 2007 Mar; 38(3):189-97. PubMed ID: 17258503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K; Reisinger K
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The epidemiology behind the HPV vaccine discovery.
    Koutsky L
    Ann Epidemiol; 2009 Apr; 19(4):239-44. PubMed ID: 19344861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines for human papillomavirus infection: a critical analysis.
    Nath AK; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(3):245-53; quiz 254. PubMed ID: 19439876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing human papillomavirus vaccines - questions remain.
    Paavonen J; Lehtinen M
    Ann Med; 2008; 40(3):162-6. PubMed ID: 18382882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Education about human papillomavirus and human papillomavirus vaccines in adolescents.
    Kollar LM; Kahn JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):479-83. PubMed ID: 18797272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
    Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic HPV vaccines: the Finnish perspective.
    Syrjänen KJ
    Expert Rev Vaccines; 2010 Jan; 9(1):45-57. PubMed ID: 20021305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing.
    Wheeler CM
    Nat Clin Pract Oncol; 2007 Apr; 4(4):224-35. PubMed ID: 17392713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.